Gardner Named Sequence’s Acting CEO

Chris Gardner has been named the acting CEO of St. John’s-based Sequence Bio, taking over from the company’s first CEO, Tyler Wish.
The company released a statement Wednesday saying that Gardner had assumed the position, and spokeswoman Karen Moores said that Wish is still an employee of the company. The two co-founders formed the company in 2013, carrying on the next step of genetic research